For example, TGF-β downregulates the NK cell group 2D (NKG2D) immunoreceptor, thereby reducing lytic activity and IFN-γ secretion, weakening tumor cell recognition and elimination [121, 124]. The gene discussed is TGFB1; the disease is neoplasm.